Haas R - Search Results

1

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

Germing U, Hildebrandt B, Pfeilstöcker M, Nösslinger T, Valent P, Fonatsch C, Lübbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis AA, Strupp C, Kündgen A, Mueller T, Haas R, Gattermann N, Aul C. Germing U, et al. Among authors: haas r. Leukemia. 2005 Dec;19(12):2223-31. doi: 10.1038/sj.leu.2403963. Leukemia. 2005. PMID: 16193087

2

[Aspects of internal medicine].

Haas R, Germing U. Haas R, et al. Radiologe. 2000 Jun;40(6):495-9. doi: 10.1007/s001170050746. Radiologe. 2000. PMID: 10929385 German.

3

[Bone marrow involvement in hematologic neoplasms and solid tumors].

Martin S, Germing U, Kronenwett R, Haas R. Martin S, et al. Among authors: haas r. Radiologe. 2000 Aug;40(8):675-80. doi: 10.1007/s001170050795. Radiologe. 2000. PMID: 11006936 Review. German.

4

Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis.

Aivado M, Rong A, Germing U, Gattermann N, Kobbe G, Rieth C, Haas R, Aul C. Aivado M, et al. Among authors: haas r. Br J Haematol. 2000 Sep;110(4):884-6. doi: 10.1046/j.1365-2141.2000.02302.x. Br J Haematol. 2000. PMID: 11054075 Free article.

5

Thalidomide for the treatment of patients with myelodysplastic syndromes.

Strupp C, Germing U, Aivado M, Misgeld E, Haas R, Gattermann N. Strupp C, et al. Among authors: haas r. Leukemia. 2002 Jan;16(1):1-6. doi: 10.1038/sj.leu.2402330. Leukemia. 2002. PMID: 11840256

6

[Dynamic MRI of the lumbar spine for the evaluation of microcirculation during anti-angiogenetic therapy in patients with myelodysplastic syndromes].

Scherer A, Strupp C, Wittsack HJ, Engelbrecht V, Poll LW, Reinwand U, Willers R, Germing U, Gattermann N, Haas R, Mödder U. Scherer A, et al. Among authors: haas r. Rofo. 2002 Feb;174(2):164-9. doi: 10.1055/s-2002-20096. Rofo. 2002. PMID: 11898077 German.

7

Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports.

Strupp C, Aivado M, Germing U, Gattermann N, Haas R. Strupp C, et al. Among authors: haas r. Leuk Lymphoma. 2002 Jan;43(1):133-7. doi: 10.1080/10428190210190. Leuk Lymphoma. 2002. PMID: 11908717

8

[Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy].

Scherer A, Strupp C, Wittsack HJ, Engelbrecht V, Willers R, Germing U, Gattermann N, Haas R, Mödder U. Scherer A, et al. Among authors: haas r. Radiologe. 2002 Mar;42(3):222-30. doi: 10.1007/s00117-002-0721-6. Radiologe. 2002. PMID: 11963240 German.

9

Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.

Aivado M, Rong A, Stadler M, Germing U, Giagounidis A, Strupp C, Novotny J, Josten KM, Kobbe G, Hildebrandt B, Gattermann N, Aul C, Haas R, Ganser A. Aivado M, et al. Among authors: haas r. Eur J Haematol. 2002 Apr;68(4):210-6. doi: 10.1034/j.1600-0609.2002.01625.x. Eur J Haematol. 2002. PMID: 12071936 Clinical Trial.

10

[Does dynamic contrast-enhanced MRI enable recognition of development of vertebral fractures in multiple myeloma?].

Scherer A, Wittsack HJ, Engelbrecht V, Strupp C, Poll LW, Willers R, Schneider P, Gattermann N, Haas R, Mödder U. Scherer A, et al. Among authors: haas r. Rofo. 2002 Aug;174(8):984-90. doi: 10.1055/s-2002-32920. Rofo. 2002. PMID: 12142975 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,933 results

Search Page

Filters